Cancer jab can eradicate entire tumours in patients, trial shows
A new cancer treatment trial has shown promising results, with a jab called amivantamab able to eradicate tumors in some patients. The trial involved 102 patients with head and neck cancer, and over a third experienced significant tumor shrinkage. This treatment could potentially benefit many patients who have limited options due to resistance to traditional therapies.
- ▪The amivantamab jab shrank tumors in more than a third of patients in the trial.
- ▪Fifteen patients had their tumors completely eradicated after treatment.
- ▪The jab is administered under the skin, making it more convenient than traditional intravenous treatments.
Opening excerpt (first ~120 words) tap to expand
Carl Walsh, 56, who was diagnosed with tongue cancer in May 2024, joined the OrigAMI-4 trial at the Royal Marsden in July 2025. Photograph: HandoutView image in fullscreenCarl Walsh, 56, who was diagnosed with tongue cancer in May 2024, joined the OrigAMI-4 trial at the Royal Marsden in July 2025. Photograph: HandoutCancer researchCancer jab can eradicate entire tumours in patients, trial showsJab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapyAndrew Gregory Health editor, in ChicagoSat 30 May 2026 13.00 EDTLast modified on Sat 30 May 2026 13.01 EDTSharePrefer the Guardian on GoogleDoctors have hailed “unprecedented” trial results that show a triple-action cancer jab can eradicate entire tumours in patients.In an…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — World.
Discussion
0 commentsMore from The Guardian — World
